Riddle M M, Williams W C, Smialowicz R J
National Health and Environmental Effects Research Laboratory, U.S. Enviromental Protection Agency, Research Triangle Park, NC 27711, USA.
Toxicology. 1996 May 3;109(1):67-74. doi: 10.1016/0300-483x(96)03306-9.
2-Methoxyethanol (ME) has been shown to be immunosuppressive in rats but not mice, with oxidation of ME to 2-methoxyacetic acid (MAA) being a prerequisite for immunosuppression. MAA is more rapidly cleared by mice than rats, consequently this study was designed to determine if increasing the bioavailability of MAA in mice might play a role in this species difference. Female B6C3F1 mice were given MAA by oral multiple daily high doses or by continuous subcutaneous infusion via mini-osmotic pumps. Humoral immunity was evaluated in MAA-exposed mice using the plaque-forming cell (PFC) response to either sheep red blood cells (SRBC) or trinitrophenyl-lipopolysaccharide (TNP-LPS). Female F344 rats were also used to compare the effects of multiple daily MAA exposure on these humoral immune responses. Rats and mice were dosed orally twice a day for 4 days by gavage with MAA at dosages ranging from 40-320 mg/kg/day and 240-1920 mg/kg/day, respectively. All animals were immunized on the first day of dosing and body and lymphoid organ weights and PFC responses to SRBC or TNP-LPS were evaluated 4 days later. While body weights in rats were unaffected, thymus weights were reduced at all dosages of MAA and spleen weights were reduced at 160 or 320 mg/kg/day. PFC responses to SRBC and TNP-LPS were suppressed in rats at dosages of 160 and 320 mg/kg/day. In contrast, thymus weights of mice were reduced only at 960 mg/kg/day or greater, with no effect on spleen or body weights. Furthermore, neither the PFC response to SRBC nor the response to TNP-LPS was suppressed in mice exposed to any oral dosage of MAA. In the continuous infusion study, mice were subcutaneously implanted with mini-osmotic pumps containing MAA which was delivered at 840 mg/kg/day over a 7-day period. Continuous exposure to MAA via mini-osmotic pumps did not suppress the PFC response to either SRBC or TNP-LPS, but rather significantly enhanced the response to TNP-LPS. These results indicate that mice are insensitive to MAA even at the high dosages given as a bolus or continuously over 1 week. The data further support earlier work, which suggested that the observed difference between rats and mice for MAA-induced immunosuppression appears to be unrelated to the availability of MAA to target lymphoid tissue in these rodent species.
2-甲氧基乙醇(ME)已被证明在大鼠中具有免疫抑制作用,但在小鼠中则不然,ME氧化为2-甲氧基乙酸(MAA)是免疫抑制的前提条件。与大鼠相比,小鼠清除MAA的速度更快,因此本研究旨在确定提高小鼠体内MAA的生物利用度是否可能在这种物种差异中起作用。通过每日多次高剂量口服或通过微型渗透泵连续皮下输注的方式给雌性B6C3F1小鼠给予MAA。使用对绵羊红细胞(SRBC)或三硝基苯基-脂多糖(TNP-LPS)的空斑形成细胞(PFC)反应来评估暴露于MAA的小鼠的体液免疫。还使用雌性F344大鼠来比较每日多次暴露于MAA对这些体液免疫反应的影响。大鼠和小鼠分别通过灌胃,每天口服两次,连续4天,给予MAA,剂量范围分别为40-320mg/kg/天和240-1920mg/kg/天。所有动物在给药的第一天进行免疫,4天后评估体重、淋巴器官重量以及对SRBC或TNP-LPS的PFC反应。虽然大鼠的体重未受影响,但在所有MAA剂量下胸腺重量均降低,在160或320mg/kg/天的剂量下脾脏重量降低。在160和320mg/kg/天的剂量下,大鼠对SRBC和TNP-LPS的PFC反应受到抑制。相比之下,仅在960mg/kg/天及以上剂量时小鼠的胸腺重量降低,对脾脏或体重无影响。此外,暴露于任何口服剂量MAA的小鼠对SRBC的PFC反应和对TNP-LPS的反应均未受到抑制。在连续输注研究中,给小鼠皮下植入含有MAA的微型渗透泵,以840mg/kg/天的剂量在7天内进行输注。通过微型渗透泵持续暴露于MAA并未抑制对SRBC或TNP-LPS的PFC反应,反而显著增强了对TNP-LPS的反应。这些结果表明,即使以大剂量或连续1周给予高剂量,小鼠对MAA也不敏感。数据进一步支持了早期的研究工作,该研究表明观察到的大鼠和小鼠在MAA诱导的免疫抑制方面的差异似乎与这些啮齿动物物种中MAA进入靶淋巴组织的可用性无关。